Article info
PDFCoronary artery disease
The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction
- Correspondence to:
J Brophy
Cardiology Division, Room M4.76, McGill University Health Centre, Royal Victoria Hospital, 687 Pine Avenue West, Montréal, Québec, Canada H3A 1A1;james.brophy{at}mcgill.ca
Citation
The coronary risk of cyclo-oxygenase-2 inhibitors in patients with a previous myocardial infarction
Publication history
- Accepted July 3, 2006
- First published July 18, 2006.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2007 by Heart